首页 > 最新文献

CJC Open最新文献

英文 中文
Adverse Drug Events Associated with Optimizing Heart Failure Pharmacotherapy in Older Adults with Frailty: A Qualitative Study 与优化老年人虚弱心衰药物治疗相关的药物不良事件:一项定性研究
IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.cjco.2025.06.019
Mai H. Duong PhD, BScPharm , Danijela Gnjidic PhD , Andrew J. McLachlan PhD, BPharm , Lisa Kouladjian O’Donnell PhD, MPharm , Ritu Trivedi PhD , Rebecca Kozor PhD, MD , Sarah N. Hilmer PhD, MD

Background

Adverse drug events (ADEs) from heart failure (HF) pharmacotherapy are common in older people with frailty, but evidence as to how to optimize HF pharmacotherapy is unclear. This qualitative study explores consumer and healthcare professional (HCP) perspectives on ADEs and adverse drug withdrawal effects (ADWEs) related to HF pharmacotherapy to inform key domains of a conceptual model.

Methods

A purposive and snowball sample of participants were contacted directly or recruited across Australia and New Zealand to participate in qualitative semistructured interviews and focus groups. Frailty was explained as a measure of cumulative deficits and consumers (caregivers or individuals aged ≥ 65 years with HF and frailty) and HCPs caring for older patients with HF and frailty were invited according to their self-perception or evaluation of frailty. General inductive analysis identified themes and a hypothesis-generating conceptual model.

Results

Thirty-two participants were recruited (consumers [n = 4), cardiologists and other physicians [n = 9], nurses [n = 8], and pharmacists [n = 11]). Three main themes and 8 subthemes related to individual factors, medications, and access to healthcare services were identified. Consumers stated that they want support to maintain their quality of life but have complex medical issues. Most HCP participants perceived the benefits of HF pharmacotherapy to outweigh the risks of ADEs and are hesitant to deprescribe. Participants wanted improved coordination of multidisciplinary teams and patient access to healthcare services.

Conclusions

Perspectives unique to HF pharmacotherapy in older people with frailty characterize how the interplay of HF treatment, ADEs, and ADWEs contributes to individuals’ well-being. Future research is needed to further develop the conceptual model.
心衰(HF)药物治疗引起的药物不良事件(ADEs)在虚弱的老年人中很常见,但关于如何优化心衰药物治疗的证据尚不清楚。本定性研究探讨了消费者和医疗保健专业人员(HCP)对与心衰药物治疗相关的不良反应和药物戒断反应(ADWEs)的看法,以告知概念模型的关键领域。方法直接联系或在澳大利亚和新西兰招募有目的的滚雪球式样本参与者,参与定性半结构化访谈和焦点小组。虚弱被解释为一种累积缺陷的测量,消费者(照顾者或年龄≥65岁的HF和虚弱个体)和照顾老年HF和虚弱患者的HCPs根据他们的自我感知或虚弱评估被邀请。一般归纳分析确定主题和假设生成的概念模型。结果共招募了32名参与者(消费者[n = 4)、心内科及其他医师[n = 9]、护士[n = 8]、药剂师[n = 11])。确定了与个人因素、药物和获得保健服务有关的三个主题和8个次级主题。消费者表示,他们希望得到支持以维持生活质量,但有复杂的医疗问题。大多数HCP参与者认为心衰药物治疗的益处大于ade的风险,因此不愿取消处方。与会者希望改善多学科小组的协调和病人获得保健服务的机会。结论:老年虚弱患者心衰药物治疗的独特视角描述了心衰治疗、ADEs和ADWEs如何相互作用,从而促进个体的健康。未来的研究需要进一步发展概念模型。
{"title":"Adverse Drug Events Associated with Optimizing Heart Failure Pharmacotherapy in Older Adults with Frailty: A Qualitative Study","authors":"Mai H. Duong PhD, BScPharm ,&nbsp;Danijela Gnjidic PhD ,&nbsp;Andrew J. McLachlan PhD, BPharm ,&nbsp;Lisa Kouladjian O’Donnell PhD, MPharm ,&nbsp;Ritu Trivedi PhD ,&nbsp;Rebecca Kozor PhD, MD ,&nbsp;Sarah N. Hilmer PhD, MD","doi":"10.1016/j.cjco.2025.06.019","DOIUrl":"10.1016/j.cjco.2025.06.019","url":null,"abstract":"<div><h3>Background</h3><div>Adverse drug events (ADEs) from heart failure (HF) pharmacotherapy are common in older people with frailty, but evidence as to how to optimize HF pharmacotherapy is unclear. This qualitative study explores consumer and healthcare professional (HCP) perspectives on ADEs and adverse drug withdrawal effects (ADWEs) related to HF pharmacotherapy to inform key domains of a conceptual model.</div></div><div><h3>Methods</h3><div>A purposive and snowball sample of participants were contacted directly or recruited across Australia and New Zealand to participate in qualitative semistructured interviews and focus groups. Frailty was explained as a measure of cumulative deficits and consumers (caregivers or individuals aged ≥ 65 years with HF and frailty) and HCPs caring for older patients with HF and frailty were invited according to their self-perception or evaluation of frailty. General inductive analysis identified themes and a hypothesis-generating conceptual model.</div></div><div><h3>Results</h3><div>Thirty-two participants were recruited (consumers [n = 4), cardiologists and other physicians [n = 9], nurses [n = 8], and pharmacists [n = 11]). Three main themes and 8 subthemes related to individual factors, medications, and access to healthcare services were identified. Consumers stated that they want support to maintain their quality of life but have complex medical issues. Most HCP participants perceived the benefits of HF pharmacotherapy to outweigh the risks of ADEs and are hesitant to deprescribe. Participants wanted improved coordination of multidisciplinary teams and patient access to healthcare services.</div></div><div><h3>Conclusions</h3><div>Perspectives unique to HF pharmacotherapy in older people with frailty characterize how the interplay of HF treatment, ADEs, and ADWEs contributes to individuals’ well-being. Future research is needed to further develop the conceptual model.</div></div>","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"7 10","pages":"Pages 1301-1313"},"PeriodicalIF":2.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145335047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous Pacing and Recording Technique: A Real-Time Feedback Approach for Left Bundle Branch Pacing 连续起搏和记录技术:左束支起搏的实时反馈方法
IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.cjco.2025.07.008
Jiabo Shen MD , Longfu Jiang MD , Hao Wu MD , Hengdong Li MD
Left bundle branch pacing demonstrates significant clinical value in both prevention of right ventricular pacing-induced cardiomyopathy and resynchronization therapy following left bundle branch block. The current intermittent recording technique requires repeated interruptions during implantation to test parameters, increasing procedural complexity and time. In recent years, the application of stylet-driven leads and rotatable connectors combined with lumenless leads has enabled a continuous pacing and recording technique. This approach facilitates beat-by-beat monitoring of electrocardiograms and intracardiac electrograms during lead implantation, with real-time electrophysiological feedback provided to assist operators in precisely determining lead positioning and confirming left bundle branch capture. This technological innovation not only enhances procedural precision but also substantially improves operational safety. In addition, the continuous recording technique offers novel perspectives for electrophysiological research, potentially bridging cardiac pacing to advanced electrophysiological therapeutic strategies.
左束支起搏在预防右室起搏引起的心肌病和左束支阻滞后的再同步化治疗方面具有重要的临床价值。目前的间歇记录技术需要在植入过程中反复中断以测试参数,增加了程序的复杂性和时间。近年来,风格驱动引线和可旋转连接器与无流明引线相结合的应用使连续起搏和记录技术成为可能。这种方法有助于在导联植入过程中对心电图和心内心电图进行实时监测,并提供实时电生理反馈,以帮助操作人员精确确定导联定位并确认左束分支捕获。这一技术创新不仅提高了程序精度,而且大大提高了操作安全性。此外,连续记录技术为电生理研究提供了新的视角,有可能将心脏起搏与先进的电生理治疗策略联系起来。
{"title":"Continuous Pacing and Recording Technique: A Real-Time Feedback Approach for Left Bundle Branch Pacing","authors":"Jiabo Shen MD ,&nbsp;Longfu Jiang MD ,&nbsp;Hao Wu MD ,&nbsp;Hengdong Li MD","doi":"10.1016/j.cjco.2025.07.008","DOIUrl":"10.1016/j.cjco.2025.07.008","url":null,"abstract":"<div><div>Left bundle branch pacing demonstrates significant clinical value in both prevention of right ventricular pacing-induced cardiomyopathy and resynchronization therapy following left bundle branch block. The current intermittent recording technique requires repeated interruptions during implantation to test parameters, increasing procedural complexity and time. In recent years, the application of stylet-driven leads and rotatable connectors combined with lumenless leads has enabled a continuous pacing and recording technique. This approach facilitates beat-by-beat monitoring of electrocardiograms and intracardiac electrograms during lead implantation, with real-time electrophysiological feedback provided to assist operators in precisely determining lead positioning and confirming left bundle branch capture. This technological innovation not only enhances procedural precision but also substantially improves operational safety. In addition, the continuous recording technique offers novel perspectives for electrophysiological research, potentially bridging cardiac pacing to advanced electrophysiological therapeutic strategies.</div></div>","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"7 10","pages":"Pages 1357-1365"},"PeriodicalIF":2.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145334552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of the CR-DECIDE Models to Predict Major Adverse Cardiovascular Events and Health Status in Stable Coronary Artery Disease CR-DECIDE模型在稳定型冠状动脉疾病中预测主要不良心血管事件和健康状况的发展和验证
IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.cjco.2025.07.001
Ricky D. Turgeon BSc(Pharm), ACPR, PharmD , May K. Lee MSc , Rubee Dev MPH, PhD , Colleen M. Norris BScN, MScN, PhD , John A. Spertus MD , Karin H. Humphries DSc

Background

Guidelines emphasize individualized care in the management of stable coronary artery disease (CAD). We aimed to develop and validate clinical prediction models for major adverse cardiovascular events (MACEs) and health status among patients with stable CAD to support individualized, shared decision-making.

Methods

For model development and internal validation, we used registries of outpatients with obstructive CAD on coronary angiography in British Columbia (2004-2015) and Alberta (2004-2020). Models were externally validated in ISCHEMIA trial participants with obstructive CAD on coronary computed tomography angiography. Outcomes included MACE (death, myocardial infarction, or stroke) within 3 years, angina-free status, and good-to-excellent physical functioning at 1 year, based on the Seattle Angina Questionnaire.

Results

Median age was of study patients was 66-67 years, and 77% were male in both the MACE (n = 34,990) and health status (n = 13,312) model development cohorts. MACEs occurred in 9% (2026 patients) at 3 years. A 14-variable model had a C statistic of 0.68, calibration slope of 0.98, and positive net benefit in decision-curve analysis. At baseline, 41% were angina-free and 21% had good-to-excellent physical functioning, which increased to 64.5% and 72% at 1 year, respectively. C statistics for the angina-free and physical functioning models were 0.67 and 0.78, respectively, and calibration slopes were 0.98-0.99. In external validation, discrimination was modestly reduced and all models slightly underpredicted their respective outcomes, yet the MACE model retained positive net benefit.

Conclusions

The CR-DECIDE models had moderate ability to predict MACEs and health status in patients with stable CAD and warrant further assessment of their impact at the point of care.
背景:指南强调稳定型冠状动脉疾病(CAD)的个体化治疗。我们旨在开发和验证稳定CAD患者主要不良心血管事件(mace)和健康状况的临床预测模型,以支持个性化、共享决策。为了模型开发和内部验证,我们使用了不列颠哥伦比亚省(2004-2015)和阿尔伯塔省(2004-2020)的阻塞性CAD门诊患者冠状动脉造影登记。模型在冠状动脉计算机断层血管造影上对患有阻塞性CAD的缺血试验参与者进行了外部验证。结果包括3年内的MACE(死亡、心肌梗死或中风)、无心绞痛状态和1年内良好至优秀的身体功能,基于西雅图心绞痛问卷。结果研究患者的中位年龄为66-67岁,在MACE (n = 34,990)和健康状况(n = 13,312)模型开发队列中,77%为男性。3年时,9%(2026例)的患者出现了mace。14变量模型在决策曲线分析中的C统计量为0.68,校正斜率为0.98,净效益为正。在基线时,41%的患者无心绞痛,21%的患者身体功能良好至优异,1年后分别增加到64.5%和72%。无心绞痛模型和生理功能模型的C统计量分别为0.67和0.78,校正斜率为0.98-0.99。在外部验证中,歧视适度减少,所有模型都略微低估了各自的结果,但MACE模型保留了正净效益。结论CR-DECIDE模型对稳定型CAD患者的mace和健康状况有中等预测能力,值得在护理点进一步评估其影响。
{"title":"Development and Validation of the CR-DECIDE Models to Predict Major Adverse Cardiovascular Events and Health Status in Stable Coronary Artery Disease","authors":"Ricky D. Turgeon BSc(Pharm), ACPR, PharmD ,&nbsp;May K. Lee MSc ,&nbsp;Rubee Dev MPH, PhD ,&nbsp;Colleen M. Norris BScN, MScN, PhD ,&nbsp;John A. Spertus MD ,&nbsp;Karin H. Humphries DSc","doi":"10.1016/j.cjco.2025.07.001","DOIUrl":"10.1016/j.cjco.2025.07.001","url":null,"abstract":"<div><h3>Background</h3><div>Guidelines emphasize individualized care in the management of stable coronary artery disease (CAD). We aimed to develop and validate clinical prediction models for major adverse cardiovascular events (MACEs) and health status among patients with stable CAD to support individualized, shared decision-making.</div></div><div><h3>Methods</h3><div>For model development and internal validation, we used registries of outpatients with obstructive CAD on coronary angiography in British Columbia (2004-2015) and Alberta (2004-2020). Models were externally validated in ISCHEMIA trial participants with obstructive CAD on coronary computed tomography angiography. Outcomes included MACE (death, myocardial infarction, or stroke) within 3 years, angina-free status, and good-to-excellent physical functioning at 1 year, based on the Seattle Angina Questionnaire.</div></div><div><h3>Results</h3><div>Median age was of study patients was 66-67 years, and 77% were male in both the MACE (n = 34,990) and health status (n = 13,312) model development cohorts. MACEs occurred in 9% (2026 patients) at 3 years. A 14-variable model had a C statistic of 0.68, calibration slope of 0.98, and positive net benefit in decision-curve analysis. At baseline, 41% were angina-free and 21% had good-to-excellent physical functioning, which increased to 64.5% and 72% at 1 year, respectively. C statistics for the angina-free and physical functioning models were 0.67 and 0.78, respectively, and calibration slopes were 0.98-0.99. In external validation, discrimination was modestly reduced and all models slightly underpredicted their respective outcomes, yet the MACE model retained positive net benefit.</div></div><div><h3>Conclusions</h3><div>The CR-DECIDE models had moderate ability to predict MACEs and health status in patients with stable CAD and warrant further assessment of their impact at the point of care.</div></div>","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"7 10","pages":"Pages 1398-1406"},"PeriodicalIF":2.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145334588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Takotsubo T Waves---a Diagnostically Useful Electrocardiographic Pattern in 10 Case Presentations Takotsubo T波——10例诊断有用的心电图模式
IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-01 DOI: 10.1016/j.cjco.2025.06.010
Everglad Mugutso MBChB, MSc , Brent M. McGrath MD, MSc, PhD, FACC, FSCAI, FRCPC, DRCPSC
{"title":"Takotsubo T Waves---a Diagnostically Useful Electrocardiographic Pattern in 10 Case Presentations","authors":"Everglad Mugutso MBChB, MSc ,&nbsp;Brent M. McGrath MD, MSc, PhD, FACC, FSCAI, FRCPC, DRCPSC","doi":"10.1016/j.cjco.2025.06.010","DOIUrl":"10.1016/j.cjco.2025.06.010","url":null,"abstract":"","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"7 9","pages":"Pages 1198-1200"},"PeriodicalIF":2.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complete Heart Block Due to High Vagal Tone in Pregnancy 妊娠期迷走神经张力高导致完全性心脏传导阻滞
IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-01 DOI: 10.1016/j.cjco.2025.06.001
Ella Maria Cockburn BCS, MD , Jessica Yao BBMed, MD , Robert Anderson BMedSci (Hons), MBBS (Hons), PhD, FRACP
{"title":"Complete Heart Block Due to High Vagal Tone in Pregnancy","authors":"Ella Maria Cockburn BCS, MD ,&nbsp;Jessica Yao BBMed, MD ,&nbsp;Robert Anderson BMedSci (Hons), MBBS (Hons), PhD, FRACP","doi":"10.1016/j.cjco.2025.06.001","DOIUrl":"10.1016/j.cjco.2025.06.001","url":null,"abstract":"","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"7 9","pages":"Pages 1263-1265"},"PeriodicalIF":2.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human-Centred Design & Development of a Shared Decision Aid for Patients with Chronic Kidney Disease Facing Treatment for Coronary Heart Disease 面向冠心病治疗的慢性肾病患者共享决策辅助系统的人本设计与开发
IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-01 DOI: 10.1016/j.cjco.2025.06.004
Julie Babione MSc , Denise Kruger II RTR , Pantea Javaheri MSc , Todd Wilson PhD , Winnie Pearson (Patient Partner) , Wayne Gerber (Patient Partner) , Loretta Lee (Patient Partner) , Krystina B. Lewis PhD, RN, CCN(C) , Michelle M. Graham MD, FRCPC, FCCS , Stephen B. Wilton MD, MSc , Matthew T. James MD, PhD, FRCPC

Background

Coronary artery disease (CAD) commonly accompanies chronic kidney disease (CKD) and carries unique management considerations for people with CKD. Shared decision-making (SDM) is a collaborative approach in which patients and physicians make decisions together based on a shared understanding of the health condition, treatment options and attributes, patient values and preferences, and risk tolerance. Our objective was to support SDM by creating a decision aid for patients with CKD and physicians addressing invasive vs conservative CAD treatment options, which included personalized risk estimates for treatment option attributes, and identification of patient values and preferences.

Methods

Applying human-centred design, informed by the International Patient Decision Aid Standard and Ottawa Decision Support Framework, we created a personalized shared decision aid. A concurrent mixed-methods study involved patients and physicians evaluating content, features, implementation contexts, and guided design. Survey data analysis used descriptive statistics, and interview transcripts were analyzed using deductive content analysis.

Results

Thirty-two patients (47% aged < 65 years; 47% women) and 18 physicians (72% aged < 50 years; 22% women) evaluated successive decision-aid iterations, providing design and implementation perspectives. Most received decision-aid content positively, and the design was refined over 3 development iterations. Overarching development-informing themes were as follows: (i) facilitating patient-physician interactions and knowledge-sharing to enable SDM; (ii) responding to contextual end-user needs for decision-making; and (iii) supporting flexible workflow use and integration. The decision aid is available at: https://myheartandckd.ca.

Conclusions

Human-centred design processes effectively guided creation of a decision aid for patients with CKD and physicians making shared CAD treatment decisions. Findings will inform future clinical implementation strategies.
背景冠状动脉疾病(CAD)通常伴随慢性肾脏疾病(CKD),对CKD患者有独特的管理考虑。共同决策(SDM)是一种协作方法,在这种方法中,患者和医生基于对健康状况、治疗方案和属性、患者价值观和偏好以及风险承受能力的共同理解共同做出决策。我们的目标是通过为CKD患者和医生提供有创与保守CAD治疗方案的决策辅助来支持SDM,包括治疗方案属性的个性化风险评估,以及患者价值和偏好的识别。方法采用以人为本的设计,在国际患者决策辅助标准和渥太华决策支持框架的指导下,我们创建了一个个性化的共享决策辅助系统。一项同时进行的混合方法研究涉及患者和医生评估内容、特征、实施环境和指导设计。调查数据分析采用描述性统计,访谈记录分析采用演绎内容分析。结果32名患者(47% 65岁,47%女性)和18名医生(72% 50岁,22%女性)评估了连续的决策辅助迭代,提供了设计和实施的观点。大多数人都对决策辅助内容持积极态度,并且设计经过3次开发迭代进行了完善。总体发展通知主题如下:(i)促进患者与医生的互动和知识共享,以实现SDM;响应最终用户的决策需要;(iii)支持灵活的工作流使用和集成。决策辅助工具可在:https://myheartandckd.ca.ConclusionsHuman-centred上获得,设计过程有效地指导了CKD患者和医生共同制定CAD治疗决策的决策辅助工具的创建。研究结果将为未来的临床实施策略提供信息。
{"title":"Human-Centred Design & Development of a Shared Decision Aid for Patients with Chronic Kidney Disease Facing Treatment for Coronary Heart Disease","authors":"Julie Babione MSc ,&nbsp;Denise Kruger II RTR ,&nbsp;Pantea Javaheri MSc ,&nbsp;Todd Wilson PhD ,&nbsp;Winnie Pearson (Patient Partner) ,&nbsp;Wayne Gerber (Patient Partner) ,&nbsp;Loretta Lee (Patient Partner) ,&nbsp;Krystina B. Lewis PhD, RN, CCN(C) ,&nbsp;Michelle M. Graham MD, FRCPC, FCCS ,&nbsp;Stephen B. Wilton MD, MSc ,&nbsp;Matthew T. James MD, PhD, FRCPC","doi":"10.1016/j.cjco.2025.06.004","DOIUrl":"10.1016/j.cjco.2025.06.004","url":null,"abstract":"<div><h3>Background</h3><div>Coronary artery disease (CAD) commonly accompanies chronic kidney disease (CKD) and carries unique management considerations for people with CKD. Shared decision-making (SDM) is a collaborative approach in which patients and physicians make decisions together based on a shared understanding of the health condition, treatment options and attributes, patient values and preferences, and risk tolerance. Our objective was to support SDM by creating a decision aid for patients with CKD and physicians addressing invasive vs conservative CAD treatment options, which included personalized risk estimates for treatment option attributes, and identification of patient values and preferences.</div></div><div><h3>Methods</h3><div>Applying human-centred design, informed by the International Patient Decision Aid Standard and Ottawa Decision Support Framework, we created a personalized <em>shared</em> decision aid. A concurrent mixed-methods study involved patients and physicians evaluating content, features, implementation contexts, and guided design. Survey data analysis used descriptive statistics, and interview transcripts were analyzed using deductive content analysis.</div></div><div><h3>Results</h3><div>Thirty-two patients (47% aged &lt; 65 years; 47% women) and 18 physicians (72% aged &lt; 50 years; 22% women) evaluated successive decision-aid iterations, providing design and implementation perspectives. Most received decision-aid content positively, and the design was refined over 3 development iterations. Overarching development-informing themes were as follows: (i) facilitating patient-physician interactions and knowledge-sharing to enable SDM; (ii) responding to contextual end-user needs for decision-making; and (iii) supporting flexible workflow use and integration. The decision aid is available at: <span><span>https://myheartandckd.ca</span><svg><path></path></svg></span>.</div></div><div><h3>Conclusions</h3><div>Human-centred design processes effectively guided creation of a decision aid for patients with CKD and physicians making shared CAD treatment decisions. Findings will inform future clinical implementation strategies.</div></div>","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"7 9","pages":"Pages 1244-1262"},"PeriodicalIF":2.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adiposity and Cardiometabolic Health Among Inuit of Nunavik: A 13-Year Follow-Up Study 努那维克因纽特人的肥胖和心脏代谢健康:一项13年的随访研究
IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-01 DOI: 10.1016/j.cjco.2025.05.016
Fannie Lajeunesse-Trempe MD-PhD , Marie-Eve Piché MD-PhD , Paul Poirier MD-PhD , Sarah O’Connor PhD , André Tchernof PhD , Pierre Ayotte PhD

Background

Obesity (body mass index [BMI] ≥ 30 kg/m2) is a major determinant of cardiometabolic health, yet the clinical impact of weight changes on cardiometabolic health in the Canadian Inuit population remains unclear.

Methods

Data were collected from 302 individuals (107 men and 195 women) who participated in the Qanuippitaa? 2004 and Qanuilirpitaa? 2017 Nunavik Inuit health surveys. Anthropometric indices (weight, BMI, waist circumference, and waist-to-height ratio, percentage of body fat, and fat-freemass), metabolic biomarkers, and hemodynamics were measured. Anthropometric characteristics and cardiometabolic risk factors were compared between 2017 and 2004 using Student paired t tests or the χ2 test, adjusted for medication. The impact of adiposity changes on cardiometabolic risk factors (blood pressure, lipid profile, and glucose homeostasis parameters) was assessed using adjusted multivariate linear regression analysis.

Results

Inuit men and women (mean baseline age: 37.1 and 36.4 years) showed a significant increase in age-standardized percentage of body fat, despite having similar BMI in 2004 and 2017. Inuit women had significant rises in age-standardized waist circumference and waist-to-height ratio (P < 0.05), whereas men’s remained stable. Increased abdominal fat was linked to adverse changes in some lipid (high-density lipoprotein cholesterol [HDL-C], total cholesterol/HDL-C ratio, apolipoprotein B) and glucose homeostasis (Homeostatic Model Assessment of Insulin Resistance) parameters (P < 0.05), but not low-density lipoprotein cholesterol, triglycerides, non-HDL-C, fasting glucose, or blood pressure.

Conclusions

Adiposity phenotypes and cardiometabolic risk factors are evolving among Nunavik Inuit, but increased abdominal fat is not linked to certain lipid parameters, fasting glucose, or blood pressure. Further research is needed to understand ethnicity-specific traits and improve management of weight-related complications.
背景:肥胖(身体质量指数[BMI]≥30 kg/m2)是心脏代谢健康的主要决定因素,但体重变化对加拿大因纽特人心脏代谢健康的临床影响尚不清楚。方法收集参加Qanuippitaa?2004年和Qanuilirpitaa?2017年努那维克因纽特人健康调查。测量人体测量指标(体重、BMI、腰围、腰高比、体脂百分比和无脂质量)、代谢生物标志物和血流动力学。采用配对t检验或χ2检验(经药物因素调整)比较2017年和2004年的人体测量特征和心脏代谢危险因素。使用调整后的多变量线性回归分析评估肥胖变化对心脏代谢危险因素(血压、血脂和葡萄糖稳态参数)的影响。结果:尽管2004年和2017年的BMI相似,但美国男性和女性(平均基线年龄分别为37.1岁和36.4岁)的年龄标准化体脂百分比显著增加。因纽特女性的年龄标准化腰围和腰高比显著上升(P < 0.05),而男性保持稳定。腹部脂肪增加与某些脂质(高密度脂蛋白胆固醇[HDL-C]、总胆固醇/HDL-C比值、载脂蛋白B)和葡萄糖稳态(胰岛素抵抗稳态模型评估)参数的不利变化有关(P < 0.05),但与低密度脂蛋白胆固醇、甘油三酯、非高密度脂蛋白c、空腹血糖或血压无关。结论努那维克因纽特人的肥胖表型和心脏代谢危险因素正在发生变化,但腹部脂肪增加与某些脂质参数、空腹血糖或血压无关。需要进一步的研究来了解种族特异性特征并改善体重相关并发症的管理。
{"title":"Adiposity and Cardiometabolic Health Among Inuit of Nunavik: A 13-Year Follow-Up Study","authors":"Fannie Lajeunesse-Trempe MD-PhD ,&nbsp;Marie-Eve Piché MD-PhD ,&nbsp;Paul Poirier MD-PhD ,&nbsp;Sarah O’Connor PhD ,&nbsp;André Tchernof PhD ,&nbsp;Pierre Ayotte PhD","doi":"10.1016/j.cjco.2025.05.016","DOIUrl":"10.1016/j.cjco.2025.05.016","url":null,"abstract":"<div><h3>Background</h3><div>Obesity (body mass index [BMI] ≥ 30 kg/m<sup>2</sup>) is a major determinant of cardiometabolic health, yet the clinical impact of weight changes on cardiometabolic health in the Canadian Inuit population remains unclear.</div></div><div><h3>Methods</h3><div>Data were collected from 302 individuals (107 men and 195 women) who participated in the <em>Qanuippitaa?</em> 2004 and <em>Qanuilirpitaa?</em> 2017 Nunavik Inuit health surveys. Anthropometric indices (weight, BMI, waist circumference, and waist-to-height ratio, percentage of body fat, and fat-freemass), metabolic biomarkers, and hemodynamics were measured. Anthropometric characteristics and cardiometabolic risk factors were compared between 2017 and 2004 using Student paired <em>t</em> tests or the χ<sup>2</sup> test, adjusted for medication. The impact of adiposity changes on cardiometabolic risk factors (blood pressure, lipid profile, and glucose homeostasis parameters) was assessed using adjusted multivariate linear regression analysis.</div></div><div><h3>Results</h3><div>Inuit men and women (mean baseline age: 37.1 and 36.4 years) showed a significant increase in age-standardized percentage of body fat, despite having similar BMI in 2004 and 2017. Inuit women had significant rises in age-standardized waist circumference and waist-to-height ratio (<em>P</em> &lt; 0.05), whereas men’s remained stable. Increased abdominal fat was linked to adverse changes in some lipid (high-density lipoprotein cholesterol [HDL-C], total cholesterol/HDL-C ratio, apolipoprotein B) and glucose homeostasis (Homeostatic Model Assessment of Insulin Resistance) parameters (<em>P</em> &lt; 0.05), but not low-density lipoprotein cholesterol, triglycerides, non-HDL-C, fasting glucose, or blood pressure.</div></div><div><h3>Conclusions</h3><div>Adiposity phenotypes and cardiometabolic risk factors are evolving among Nunavik Inuit, but increased abdominal fat is not linked to certain lipid parameters, fasting glucose, or blood pressure. Further research is needed to understand ethnicity-specific traits and improve management of weight-related complications.</div></div>","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"7 9","pages":"Pages 1226-1235"},"PeriodicalIF":2.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter Self-Expanding Valve with a Dual Purpose—Exclusion of a Pseudoaneurysm of the Mitral-Aortic Intervalvular Fibrosa and Treatment of Aortic Stenosis 经导管自扩张瓣膜的双重目的——排除二尖瓣-主动脉瓣间纤维性假性动脉瘤和治疗主动脉瓣狭窄
IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-01 DOI: 10.1016/j.cjco.2025.05.019
Antonio Tondo MD , Alessandro Cafaro MD , Miriam Albanese MD , Marco Mussardo MD , Alessandro Mandurino-Mirizzi MD , Luca Quarta MD , Francesco Rizzo MD , Francesco Germinal RN , Dionigi Fischetti MD , Giuseppe Colonna MD
{"title":"Transcatheter Self-Expanding Valve with a Dual Purpose—Exclusion of a Pseudoaneurysm of the Mitral-Aortic Intervalvular Fibrosa and Treatment of Aortic Stenosis","authors":"Antonio Tondo MD ,&nbsp;Alessandro Cafaro MD ,&nbsp;Miriam Albanese MD ,&nbsp;Marco Mussardo MD ,&nbsp;Alessandro Mandurino-Mirizzi MD ,&nbsp;Luca Quarta MD ,&nbsp;Francesco Rizzo MD ,&nbsp;Francesco Germinal RN ,&nbsp;Dionigi Fischetti MD ,&nbsp;Giuseppe Colonna MD","doi":"10.1016/j.cjco.2025.05.019","DOIUrl":"10.1016/j.cjco.2025.05.019","url":null,"abstract":"","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"7 9","pages":"Pages 1266-1270"},"PeriodicalIF":2.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Wrist to Precision: Enhanced Atrial Flutter Detection with Modified Smartwatch Single-Lead Electrocardiogram Placement 从手腕到精确:改进的智能手表单导联心电图放置增强心房扑动检测
IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-01 DOI: 10.1016/j.cjco.2025.05.015
Yuval Avidan MD , Amir Aker MD , Razi Khoury MD , Sameha Zahra MD , Nissan Ben Dov MD , Jorge E. Schliamser MD , Asaf Danon MD, MSc

Background

Smartwatches, such as the Apple Watch (AW), are well-established tools for detecting atrial fibrillation (AF). We hypothesize that atrial flutter (AFL) is frequently misdiagnosed using traditional single-lead electrocardiogram configurations and that modified device positioning could substantially improve diagnostic accuracy.

Methods

Standard smartwatch lead-I (AW-I) recordings were obtained from 75 patients, including 25 with AFL, 25 with AF, and 25 with sinus rhythm. Additionally, modified lead-II (AW-II) recordings were collected for all AFL cases, resulting in a total of 100 tracings. Twenty blinded physicians from 4 different specialties independently analyzed all recordings.

Results

Physicians’ ability to detect AFL using the AW-I lead was poor, with only 11.6% of cases correctly identified (P = 0.362). AFL was most often misdiagnosed as AF (55.6%), undetermined (21%), or sinus rhythm (11.8%). Diagnostic accuracy improved significantly with the AW-II lead, exceeding 80% among electrophysiologists, cardiologists, and primary care physicians (P = 0.001). Variable atrioventricular conduction was associated strongly with correct diagnosis exclusively through the AW-II lead (odds ratio 1.85, 95% confidence interval 1.14-3.0, P = 0.012).

Conclusions

The standard lead-I configuration used by smartwatches is prone to misclassifying AF as AFL, particularly in the setting of variable conduction. A simple modification to lead-II positioning significantly enhances diagnostic accuracy. This adjustment may be especially valuable during post–pulmonary vein isolation surveillance and in broader clinical scenarios in which precise rhythm identification can influence therapeutic decision-making.
智能手表,如Apple Watch (AW),是检测心房颤动(AF)的成熟工具。我们假设使用传统的单导联心电图配置经常误诊心房扑动(AFL),并且修改设备定位可以大大提高诊断准确性。方法75例AFL患者25例,AF患者25例,窦性心律患者25例,采用智能手表标准导联- i (AW-I)记录。此外,收集了所有AFL病例的改良铅- ii (AW-II)记录,共进行了100次追踪。来自4个不同专业的20名盲法医生独立分析了所有记录。结果医师对AFL的检测能力较差,仅有11.6%的病例被正确识别(P = 0.362)。AFL最常误诊为房颤(55.6%)、不确定(21%)或窦性心律(11.8%)。AW-II导联显著提高了诊断准确性,电生理学家、心脏病专家和初级保健医生的诊断准确率超过80% (P = 0.001)。可变房室传导与完全通过AW-II导联的正确诊断密切相关(优势比1.85,95%可信区间1.14-3.0,P = 0.012)。结论智能手表使用的标准引线i配置容易将AF误认为AFL,特别是在可变导通设置下。对铅- ii定位的简单修改可显著提高诊断准确性。这种调整在肺静脉隔离后监测和更广泛的临床场景中可能特别有价值,在这些场景中,精确的节律识别可以影响治疗决策。
{"title":"From Wrist to Precision: Enhanced Atrial Flutter Detection with Modified Smartwatch Single-Lead Electrocardiogram Placement","authors":"Yuval Avidan MD ,&nbsp;Amir Aker MD ,&nbsp;Razi Khoury MD ,&nbsp;Sameha Zahra MD ,&nbsp;Nissan Ben Dov MD ,&nbsp;Jorge E. Schliamser MD ,&nbsp;Asaf Danon MD, MSc","doi":"10.1016/j.cjco.2025.05.015","DOIUrl":"10.1016/j.cjco.2025.05.015","url":null,"abstract":"<div><h3>Background</h3><div>Smartwatches, such as the Apple Watch (AW), are well-established tools for detecting atrial fibrillation (AF). We hypothesize that atrial flutter (AFL) is frequently misdiagnosed using traditional single-lead electrocardiogram configurations and that modified device positioning could substantially improve diagnostic accuracy.</div></div><div><h3>Methods</h3><div>Standard smartwatch lead-I (AW-I) recordings were obtained from 75 patients, including 25 with AFL, 25 with AF, and 25 with sinus rhythm. Additionally, modified lead-II (AW-II) recordings were collected for all AFL cases, resulting in a total of 100 tracings. Twenty blinded physicians from 4 different specialties independently analyzed all recordings.</div></div><div><h3>Results</h3><div>Physicians’ ability to detect AFL using the AW-I lead was poor, with only 11.6% of cases correctly identified (<em>P</em> = 0.362). AFL was most often misdiagnosed as AF (55.6%), undetermined (21%), or sinus rhythm (11.8%). Diagnostic accuracy improved significantly with the AW-II lead, exceeding 80% among electrophysiologists, cardiologists, and primary care physicians (<em>P</em> = 0.001). Variable atrioventricular conduction was associated strongly with correct diagnosis exclusively through the AW-II lead (odds ratio 1.85, 95% confidence interval 1.14-3.0, <em>P</em> = 0.012).</div></div><div><h3>Conclusions</h3><div>The standard lead-I configuration used by smartwatches is prone to misclassifying AF as AFL, particularly in the setting of variable conduction. A simple modification to lead-II positioning significantly enhances diagnostic accuracy. This adjustment may be especially valuable during post–pulmonary vein isolation surveillance and in broader clinical scenarios in which precise rhythm identification can influence therapeutic decision-making.</div></div>","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"7 9","pages":"Pages 1149-1156"},"PeriodicalIF":2.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145060784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient- and Family-Centered Care Recommendations in Cardiology Guidelines: An AI-Driven Systematic Review 心脏病学指南中以患者和家庭为中心的护理建议:一项人工智能驱动的系统评价
IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-01 DOI: 10.1016/j.cjco.2025.05.017
Sarah A. Beydoun BSc, MSc (candidate) , Catherine Gagné BSc , Noah S. Neubarth BSc , Jean-Pierre Abdallah BSc, MSc , Jillian Kifell BSc, MSc , Michael Goldfarb MD, MSc

Background

Patient- and family-centred care (PFCC) is recognized as a critical component of cardiovascular care, but its integration into cardiology society guidelines has not been described. The objective of this study is to review PFCC language use and recommendations within major cardiology society guidelines.

Methods

We conducted a systematic review of guidelines and statements from the American College of Cardiology (ACC), the American Heart Association (AHA), the Canadian Cardiovascular Society (CCS), and the European Society of Cardiology (ESC) for the period 2013-2023. PFCC-related key terms were identified using an artificial intelligence–based natural language processing algorithm, and recommendations were categorized into 8 dimensions of PFCC. The inclusion of PFCC recommendations across societies and trends over time were examined.

Results

A total of 260 guidelines and statements were analyzed. The most frequent PFCC dimensions overall were Health Transitions (23.5 per 100 pages), Shared Decision-Making (11.1 per 100 pages), and Care Access (9.9 per 100 pages). The least commonly identified dimensions across all journals were Care Coordination (6.5 per 100 pages), Emotional Support (4.0 per 100 pages), and Familial Support (1.0 per 100 pages). The CCS, ACC, and AHA had more recommendations using PFCC key terms than the ESC per 100 pages (17.3, 12.0, 10.3 vs 4.6, respectively, P < 0.01). PFCC language usage increased markedly over the 10-year period for the ACC, AHA, and ESC, but it decreased for the CCS (all P < 0.05).

Conclusions

PFCC language and recommendations are being included increasingly in cardiology society guidelines. Differences exist in PFCC language use across these societies. Future research is needed to evaluate the impact of these guideline recommendations on clinical practice.
以患者和家庭为中心的护理(PFCC)被认为是心血管护理的关键组成部分,但其纳入心脏病学会指南尚未描述。本研究的目的是回顾主要心脏病学会指南中PFCC语言的使用和建议。方法:我们对2013-2023年期间美国心脏病学会(ACC)、美国心脏协会(AHA)、加拿大心血管学会(CCS)和欧洲心脏病学会(ESC)的指南和声明进行了系统回顾。使用基于人工智能的自然语言处理算法识别PFCC相关关键术语,并将建议分为PFCC的8个维度。研究了全社会PFCC建议的纳入情况和长期趋势。结果共分析了260份指南和声明。总体而言,最常见的PFCC维度是健康转换(每100页23.5个)、共享决策(每100页11.1个)和护理获取(每100页9.9个)。所有期刊中最不常见的维度是护理协调(每100页6.5个),情感支持(每100页4.0个)和家庭支持(每100页1.0个)。CCS、ACC和AHA每100页使用PFCC关键词的推荐比ESC多(分别为17.3、12.0、10.3和4.6,P < 0.01)。在10年期间,ACC、AHA和ESC的PFCC语言使用显著增加,但CCS的PFCC语言使用减少(均P <; 0.05)。结论spfcc语言和建议越来越多地被纳入心脏病学会指南。在这些社会中,PFCC语言的使用存在差异。需要进一步的研究来评估这些指南建议对临床实践的影响。
{"title":"Patient- and Family-Centered Care Recommendations in Cardiology Guidelines: An AI-Driven Systematic Review","authors":"Sarah A. Beydoun BSc, MSc (candidate) ,&nbsp;Catherine Gagné BSc ,&nbsp;Noah S. Neubarth BSc ,&nbsp;Jean-Pierre Abdallah BSc, MSc ,&nbsp;Jillian Kifell BSc, MSc ,&nbsp;Michael Goldfarb MD, MSc","doi":"10.1016/j.cjco.2025.05.017","DOIUrl":"10.1016/j.cjco.2025.05.017","url":null,"abstract":"<div><h3>Background</h3><div>Patient- and family-centred care (PFCC) is recognized as a critical component of cardiovascular care, but its integration into cardiology society guidelines has not been described. The objective of this study is to review PFCC language use and recommendations within major cardiology society guidelines.</div></div><div><h3>Methods</h3><div>We conducted a systematic review of guidelines and statements from the American College of Cardiology (ACC), the American Heart Association (AHA), the Canadian Cardiovascular Society (CCS), and the European Society of Cardiology (ESC) for the period 2013-2023. PFCC-related key terms were identified using an artificial intelligence–based natural language processing algorithm, and recommendations were categorized into 8 dimensions of PFCC. The inclusion of PFCC recommendations across societies and trends over time were examined.</div></div><div><h3>Results</h3><div>A total of 260 guidelines and statements were analyzed. The most frequent PFCC dimensions overall were Health Transitions (23.5 per 100 pages), Shared Decision-Making (11.1 per 100 pages), and Care Access (9.9 per 100 pages). The least commonly identified dimensions across all journals were Care Coordination (6.5 per 100 pages), Emotional Support (4.0 per 100 pages), and Familial Support (1.0 per 100 pages). The CCS, ACC, and AHA had more recommendations using PFCC key terms than the ESC per 100 pages (17.3, 12.0, 10.3 vs 4.6, respectively, <em>P</em> &lt; 0.01). PFCC language usage increased markedly over the 10-year period for the ACC, AHA, and ESC, but it decreased for the CCS (all <em>P</em> &lt; 0.05).</div></div><div><h3>Conclusions</h3><div>PFCC language and recommendations are being included increasingly in cardiology society guidelines. Differences exist in PFCC language use across these societies. Future research is needed to evaluate the impact of these guideline recommendations on clinical practice.</div></div>","PeriodicalId":36924,"journal":{"name":"CJC Open","volume":"7 9","pages":"Pages 1218-1225"},"PeriodicalIF":2.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
CJC Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1